师资名录

曲海晶

助理研究员

 

邮箱: hjqu@sjtu.edu.cn

教育背景
博士毕业于东北林业大学生命科学学院,加州大学戴维斯分校联合培养博士。

工作经历
2021.7 – 2024.12 1929cc威尼斯,博士后
2025.1 – 至今 1929cc威尼斯,1929cc威尼斯,助理研究员

主要科研方向为智能纳米药物递送系统的构建及疾病免疫调控治疗。近 5 年以第一或通讯作者(含共同)在 ACS Nano、Biomaterials、Journal of Controlled Release、Acta Biomaterialia 等学术期刊发表论文10余篇,H因子11。相关工作申请国家发明专利 4 项。 担任《Exploration》2024届青年编委,《Nano TransMed》第二届青年编委。为《Journal of Nanobiotechnology》,《International Journal of Nanomedicine》等期刊审稿人。
智能纳米递送系统的构建与应用
疾病免疫治疗与调控(肿瘤与炎症疾病)
多组学联合探究纳米材料介导的生物作用机制
1. Qu, H.; Wu, J.; Pan, Y.; Abdulla, A.; Duan, Z.; Cheng, W.; Wang, N.; Chen, H.; Wang, C.; Yang, J.; Tang, J.; Yang, C.; Wu, C.*; Xue, X.*, Biomimetic Nanomodulator Regulates Oxidative and Inflammatory Stresses to Treat Sepsis-Associated Encephalopathy. ACS Nano, 2024, 18, 41, 28228–28245. 中科院 1 区, IF=15.8.
2. Chen, H.1; Qu, H.1*; Pan, Y.; Cheng, W.; Xue, X*. Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-/immuno-therapy for cancer treatments. Biomaterials, 2025, 312, 122745. 中科院 1 区, IF=12.8 (共一兼共通讯)
3. Pan, Y.1; Qu, H.1; Chen, H.; Cheng, W.; Duan, Z.; Yang, J.; Wang, N.; Wang, Y.; Wu, J.; Wang, C.; Xue, X.*, A tumor-targeting porphyrin-micelle with enhanced STING agonist delivery and synergistic photo-/immuno- therapy for cancer treatment. Acta Biomaterialia, 2025, 193, 377–391. 中科院 1 区, IF=9.4 (共一)
4. Cheng, W.; Duan, Z.; Chen, H; Wang, Y.; Wang, C.; Pan, Y.; Wu, J.; Wang, N.; Qu, H.*; Xue, X.* Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma. Acta Biomaterialia, 2025, 193, 392–405. 中科院 1 区, IF=9.4 (共通讯)
5. Qu, H.1; Li, L.1; Chen, H.; Tang, M.; Cheng, W.; Lin, T-Y.; Li, L.; Li, B.;* Xue, X.* Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments. Journal of Controlled Release, 2023, 363, 361-375. 中科院 1 区, IF=10.8
6. Xue, X.1; Qu, H.1; Bo, R.1; Zhang, D.; Zhu, Z.; Xiang, B.; Li, L.; Ricci, M.; Pan, C-X.; Lin, T-Y.; Li, Y.*; A Transformable Nanoplatform with Multiple Therapeutic and Immunostimulatory Properties for Treatment of Advanced Cancers. Biomaterials, 2023, 299, 122145.中科院 1 区, IF=15.03 (共一)
7. Qu, H.1; Yang, J1; Li, S1; Xu, J;Zhou, X; Xue, X; Zhang, D; Du, H; Shen, Y; Ramachandran, M; Zheng, H; Wu, Y; Ding, Y; Wu, H*; Ma, X*; Lin, T*; Li, Y.* Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment, Journal of Controlled Release, 2023, 357: 274-286. 中科院 1 区, IF=11.4.
8. Qu, H.1; Chen, H.1; Cheng, W.; Pan, Y.; Duan, Z.; Wang, Y.; Liang, X-J.*; Xue, X.* Charge-Reversible Crosslinked Nanoparticle for Improved Pro-Apoptotic Peptide Delivery and Synergistic Photodynamic Cancer Therapy. Nano Research, 2023, 16 (12): 13267-13282. 中科院 1 区, IF=10.269.
9. Qu, H.; Chen, H.; Cheng, W.; Wang, Y.; Xia, Y.; Zhang, L.; Ma, B.; Hu, R.*; Xue, X.*; A Supramolecular Assembly Strategy for Hydrophilic Drug Delivery towards Synergistic Cancer Treatment. Acta Biomaterialia, 2023, 164, 407. 中科院 1 区, IF=10.633
10. Qu, H1.; Jin, X1.; Cheng, W.; Wu, D.; Ma, B.; Lou, C.; Zheng, J.; Jing, L.*; Xue, X.*; Wang, Y.*, Uncovering the Fate and Risks of Intravenously injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics and Metabolomics. Particle and Fibre Toxicology, 2023, 20, 18. 中科院 1 区, IF=9.112
11. Zhang, Y.1; Qu, H.1; Xue, X.*, Blood-brain barrier penetrating liposomes with synergistic chemotherapy for glioblastoma treatment. Biomaterials Science, 2022, 10 (2), 423-434. 中科院 2区IF=7.59 (共一)

网站声明|友情链接|联系我们|返回旧版

地址:上海市东川路800号 邮编:200240
© 2020 1929cc威尼斯(中国)有限公司-BinG百科